How AI Roleplay Helps MSLs Prepare for Advisory Board Conversations They Cannot Rehearse Live

An MSL is preparing for an advisory board meeting next Tuesday. The board includes six KOLs, three of whom are globally recognised researchers in the therapeutic area. One has published the definitive meta-analysis on the topic under discussion. Another sits on the guideline committee. A third is known for being vocally critical of the company's approach to data transparency.

The MSL needs to be ready for all of them. They need to understand each person's research interests, anticipate their likely questions, prepare scientifically rigorous responses, and do all of this while staying within the boundaries of appropriate scientific exchange.

Who do they practise with?

Their manager? Probably hasn't published in the field since their own MSL days. A colleague? Might be helpful for general preparation, but can't convincingly simulate the perspective of a researcher who has spent twenty years studying the specific pathway in question. The medical director? Too busy. And even if they weren't, the dynamic of practising with your boss introduces performance anxiety that makes the rehearsal less useful.

The honest answer, for most MSLs, is that they don't practise at all. They prepare by reading. They review the KOLs' recent publications, re-read the company's data packages, study the competitive landscape, and walk into the meeting hoping that their preparation translates into performance.

Sometimes it does. Sometimes it doesn't. And when it doesn't, the consequences are significant.

Why advisory boards are uniquely high-stakes

Advisory board meetings occupy a specific position in the medical affairs calendar. They are formal engagements where the company seeks expert input on scientific and clinical questions. The KOLs present are selected for their expertise, their influence, and their willingness to share candid perspectives.

For the MSL, an advisory board is a credibility test. These are the most knowledgeable people in the field. They will ask questions that reveal whether the MSL truly understands the science or is simply relaying corporate talking points. They will challenge assumptions. They will disagree with each other, and potentially with the company's interpretation of its own data.

The stakes are high for several reasons.

Scientific credibility is everything. A KOL who concludes that an MSL doesn't understand the science at a sufficient depth will disengage. They won't argue. They won't challenge further. They'll simply stop participating meaningfully. And that assessment will colour every future interaction with the company.

Compliance boundaries are closely watched. Advisory boards sit in a regulatory grey zone that medical affairs teams navigate carefully. The discussions must remain within scientific exchange boundaries. An MSL who drifts into promotional territory, even inadvertently, creates a compliance risk that can have serious consequences. The presence of multiple KOLs, each potentially raising different topics, makes it harder to maintain boundary discipline across a full-day meeting.

Group dynamics add complexity. An advisory board is not a series of one-on-one conversations. It's a group interaction where experts respond to each other as well as to the company. Two KOLs may disagree on the interpretation of trial data. A third may raise a concern that the MSL hadn't anticipated. The MSL needs to manage these dynamics while maintaining scientific rigour and compliance awareness simultaneously.

Reputation effects compound. KOLs talk to each other. A poor performance at an advisory board doesn't just affect one relationship. It affects the company's reputation within the expert community. Conversely, an MSL who handles a challenging advisory board well builds credibility that extends well beyond the people in the room.

The specific preparation challenges

Preparing for an advisory board requires several distinct types of readiness, and most MSLs are strong in some but underprepared in others.

Understanding each KOL's perspective. Each advisory board member brings a specific viewpoint shaped by their research, their clinical experience, and their prior interactions with the company. An MSL who treats all KOLs as interchangeable experts will miss the nuances that make each conversation productive. Dr. A may be focused on sub-population analyses. Dr. B may be interested in real-world evidence that contradicts the trial findings. Dr. C may have concerns about the company's post-marketing surveillance approach. Preparing generic responses doesn't work when each expert is coming from a different angle.

Anticipating questions you haven't been asked before. The whole point of convening top experts is to get perspectives the company hasn't already considered. This means the MSL will face questions they haven't prepared for. The skill isn't in having a pre-loaded answer for every possible question. It's in being able to think through a novel question in real time, acknowledge uncertainty honestly when it exists, and redirect to available evidence when it's relevant.

Staying within boundaries under pressure. Compliance training prepares MSLs for common boundary scenarios. Advisory boards generate uncommon ones. A KOL asks about pricing strategy in the context of health technology assessment. Another asks the MSL's personal opinion on an off-label use case that their colleague across the table just mentioned publishing on. A third asks why the company's data package doesn't include the analysis they consider most important. Each of these requires a response that is scientifically appropriate, honest, and non-promotional.

Managing disagreement between experts. When two KOLs disagree during a discussion, the MSL is in a difficult position. They can't take sides without risking the relationship with the other party. They can't dismiss either perspective without appearing dismissive of legitimate scientific debate. They need to facilitate the discussion productively while keeping it focused on the agenda. This is a facilitation skill, not a scientific knowledge skill, and it's rarely trained.

How AI roleplay changes the preparation calculus

The traditional alternatives for advisory board preparation are limited. MSLs can review materials, discuss strategy with their medical director, or run through anticipated questions with a colleague. Each of these has value, but none of them simulates the actual experience of being in a room with experts who are probing the limits of your knowledge.

AI roleplay platforms can create KOL personas that reflect the characteristics of the specific experts who will be at the advisory board. Not generic expert personas, but profiles built from publicly available information: recent publications, known research interests, stated positions on relevant topics, and previous interactions with the company (where appropriately documented).

This means an MSL can practise responding to questions that are likely to come from a specific researcher, rather than generic scientific questions. If Dr. A has published extensively on the pharmacoeconomic implications of the therapy area, the simulated Dr. A will ask questions about cost-effectiveness evidence. If Dr. B has been critical of surrogate endpoint use in the field, the simulated Dr. B will challenge the company's reliance on progression-free survival data.

The practice becomes specific to the meeting rather than generic to the role.

What the practice looks like

A typical preparation sequence using AI roleplay might include several stages.

Individual KOL conversations. The MSL practises a one-on-one exchange with each simulated KOL. This surfaces the likely questions from each expert and gives the MSL a chance to refine their responses. The feedback identifies where the MSL's answers were scientifically strong, where they were vague, and where they inadvertently crossed a compliance boundary.

Group dynamic simulation. The MSL practises managing a discussion where multiple simulated KOLs interact. One disagrees with another. A third raises an unexpected topic. The MSL needs to keep the discussion productive, acknowledge competing perspectives, and steer the conversation back to the agenda without being heavy-handed. This is the aspect of advisory board management that is nearly impossible to practise through any other method.

Boundary stress-testing. The simulation deliberately introduces questions designed to push the MSL toward compliance boundaries. A direct question about commercial strategy. A request for off-label dosing guidance. A comparison with a competitor that invites a promotional response. The MSL practises redirecting these gracefully, maintaining the relationship while staying within their role.

Recovery from stumbles. The simulation includes moments where the MSL doesn't know the answer. A KOL references a paper the MSL hasn't read. A question is raised about a sub-analysis the MSL hasn't reviewed. The practice focuses on how to handle these moments honestly, neither bluffing nor freezing, but acknowledging the gap and committing to follow up. This is a skill that only develops through repeated experience with the discomfort of not knowing.

The awkwardness factor

There's a practical reason why live peer role-play doesn't work well for advisory board preparation. It feels absurd. Asking a colleague to pretend to be Professor Schmidt, the foremost authority on EGFR mutations, while you practise responding to their questions about your company's latest trial data is an exercise in mutual embarrassment.

The colleague doesn't know what Professor Schmidt would actually ask. They don't have the depth of knowledge to challenge the MSL meaningfully. And both people know they're pretending, which means neither fully commits to the exercise.

AI roleplay removes this social barrier entirely. The MSL is interacting with a system, not a person. There's no embarrassment in stumbling. No performance anxiety about what the "KOL" thinks of them personally. No concern that their colleague will judge their knowledge gaps. This psychological safety means the MSL is more likely to take risks, try different approaches, and genuinely engage with the difficult questions rather than steering toward safe ground.

It's a small point, but it matters. The whole purpose of practice is to encounter difficulty in a safe environment. If the environment doesn't feel safe, whether because of social dynamics, hierarchical concerns, or simple awkwardness, the practice loses its value.

Beyond the advisory board

The preparation skills that AI roleplay builds for advisory boards transfer to other high-stakes MSL interactions. Congress conversations with KOLs. Investigator meetings for clinical trials. Presentations to formulary committees. Any interaction where the MSL is facing experts who will test their scientific depth and where compliance boundaries are relevant.

MSLs who regularly practise against realistic KOL simulations develop a confidence that shows up in their interactions. They're less likely to be thrown by unexpected questions. They're more comfortable saying "I don't have that data, but I'll follow up" without losing composure. They handle group dynamics more smoothly because they've experienced simulated versions of the disagreements and digressions that occur in expert discussions.

This isn't about replacing genuine scientific knowledge. An MSL who doesn't understand the therapeutic area won't be saved by practice. But for MSLs who have the knowledge and need to deploy it under pressure, in front of the most demanding audience they'll ever face, regular practice is the difference between preparation and readiness.

Preparation is having the information. Readiness is being able to use it when the room is full of people who know more than you do about the subject you're discussing. AI roleplay is one of the few tools that can build the second without requiring access to the first.